For HCPs Only
Recent Clinical Updates
Loading latest clinical updates

Clinical Intelligence & Drug Records for US-Licensed Practitioners

The integrated, institutional-grade registry trusted by US-licensed practitioners for evidence-based clinical data, drug information, and peer-reviewed drug updates.

Drug Update Briefing

Weekly drug approvals, safety updates, and specialty coverage for healthcare professionals.

Clinical Resources

Drug updates, reference data, and specialist-led coverage.

Recent Clinical Updates

Latest Drug & Specialty Updates

View All

Specialty Coverage

Therapeutic-area updates for clinical review.

All Specialties

Drug Information

FDA drug records and prescribing context.

Review drug records, NDC references, dosage tools, and interaction resources alongside clinical coverage.

Clinical Coverage

Additional Drug Updates

Oncology

Pembrolizumab Plus mRNA-4157 Reduces Melanoma Recurrence: 49% Reduction in KEYNOTE-942 Trial

6h ago|4 min read|By Dr. Rahul Verma
Infectious Disease

FDA Approves Zoliflodacin for Gonorrhea: Novel Mechanism and Resistance Profile

6h ago|4 min read|By Dr. Simran Kohli
Neurology

FDA Approves Efgartigimod Alfa for Myasthenia Gravis: Home Administration for Seronegative Patients

6h ago|4 min read|By Dr. Vikram Patel
Ophthalmology

FDA Approves Yuvezzi: First Dual-Agent Eye Drop for Presbyopia Management

6h ago|4 min read|By Dr. Ravi Krishnan
Neurology

FDA Approves GTx-104 for Aneurysmal Subarachnoid Hemorrhage: 19% Hypotension Reduction in STRIVE-ON Trial

6h ago|4 min read|By Dr. Aditi Kulkarni
Neurology

FDA Approves Auvelity for Alzheimer Disease Agitation: 73% Relapse Reduction in ACCORD-2 Trial

6h ago|4 min read|By Dr. Aditi Kulkarni
Neurology

Ionis Submits NDA for Zilganersen: Antisense Oligonucleotide for Alexander Disease

6h ago|4 min read|By Dr. Aditi Kulkarni
Neurology

FDA Approves Oveporexton for Narcolepsy Type 1: 80% Reduction in Cataplexy Episodes

6h ago|4 min read|By Dr. Vikram Patel
Neurology

FDA Approves Tavapadon for Parkinson's Disease: Improved Motor Control in TEMPO Trials

6h ago|4 min read|By Dr. Aditi Kulkarni
Pulmonology

Depemokimab Shows Promise in Severe Eosinophilic Asthma: Annual Injection vs Mepolizumab and Benralizumab

7h ago|4 min read|By Dr. Nikhil Chatterjee
Gastroenterology

FDA Approves Lynavoy for Cholestatic Pruritus: Treatment of Primary Biliary Cholangitis

7h ago|4 min read|By Dr. Sanjay Iyer
Immunology

FDA Approves Donidalorsen for Hereditary Angioedema Prophylaxis: 70% Reduction in Attack Rate

7h ago|5 min read|By Dr. Aarti Ghosh
Cardiology

Abelacimab Reduces Stroke Risk: AZALEA-TIMI 71 Trial Shows Improved Safety Profile in Atrial Fibrillation

7h ago|5 min read|By Dr. Kavya Sharma
Infectious Disease

FDA Approves Zoliflodacin for Uncomplicated Gonorrhea: First New Antibiotic Class in Decades

7h ago|4 min read|By Dr. Simran Kohli
Psychiatry

FDA Approves CTx-1301 for ADHD: Novel Triple Release Formulation Eliminates Midday Rebound

May 29|3 min read|By Dr. Mohit Joshi
Dermatology

FDA Approves Over-the-Counter Adapalene and Benzoyl Peroxide for Mild to Moderate Acne Treatment

May 29|3 min read|By Dr. Divya Agarwal
Rheumatology

FDA Approves First Interchangeable Biosimilars for Rheumatoid Arthritis: Cost Savings and Formulary Implications

May 29|3 min read|By Dr. Deepak Nair
Pulmonology

WHO Releases 2026 Smoking Cessation Guidelines: Cytisinicline vs Varenicline vs NRT vs Bupropion

May 29|3 min read|By Dr. Nikhil Chatterjee
Oncology

Zanubrutinib and Acalabrutinib: New Treatment Paradigms for Mantle Cell Lymphoma

May 29|3 min read|By Dr. Rahul Verma
Infectious Disease

COVID-19 Treatment Options: Comparing Ensitrelvir, Paxlovid, and Lagevrio

May 29|3 min read|By Dr. Simran Kohli
Cardiology

Baxdrostat Reduces Resistant Hypertension: New Treatment Algorithm for 2026

May 29|3 min read|By Dr. Kavya Sharma
Gastroenterology

FDA Approves New Biologics Algorithm for Ulcerative Colitis: Golimumab, Vedolizumab, Upadacitinib, and More

May 29|3 min read|By Dr. Sanjay Iyer
Infectious Disease

CDC Updates Hepatitis B Vaccination Guidelines: Universal Vaccination for Adults 19-59 and Catch-Up for Those Over 60

May 29|3 min read|By Dr. Simran Kohli